-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hao5o2l6VM8A/3e/O9FVEvSmjmUQ3YMa1qF8TseFf8IYPbEU47s6HQ9gRcg+hhx2 0QilOkwaCvepD5MLc8Aomg== 0001307942-07-000078.txt : 20070515 0001307942-07-000078.hdr.sgml : 20070515 20070515103355 ACCESSION NUMBER: 0001307942-07-000078 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070515 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070515 DATE AS OF CHANGE: 20070515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLONDER TONGUE LABORATORIES INC CENTRAL INDEX KEY: 0001000683 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 521611421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14120 FILM NUMBER: 07849983 BUSINESS ADDRESS: STREET 1: ONE JAKE BROWN RD STREET 2: PO BOX 1000 CITY: OLD BRIDGE STATE: NJ ZIP: 08857 BUSINESS PHONE: 9086794000 MAIL ADDRESS: STREET 1: ONE JAKE BROWN ROAD CITY: OLD BRIDGE STATE: NJ ZIP: 08857 8-K 1 blonder8k051507.htm EARNINGS RELEASE
4
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): May 15, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



         Delaware                        1-14120                   52-1611421
     (State or other              (Commission File Number)    (I.R.S. Employer
jurisdiction of incorporation)                               Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))







Item 2.02.  Results of Operations and Financial Condition

On May 15,  2007,  Blonder  Tongue  Laboratories,  Inc.  issued a press  release
announcing its unaudited financial results for the first quarter ended March 31,
2007. A copy of the press release is attached to this Report as Exhibit 99.1 and
is incorporated herein by reference.  The information  disclosed in this report,
including  Exhibit  99.1  hereto,  is being  furnished  and  shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

Item 9.01.  Financial Statements and Exhibits

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated May 15, 2007.







                                       2



                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:   /s/ Eric Skolnik
                                         Eric Skolnik
                                         Senior Vice President
                                         and Chief Financial Officer

Date: May 15, 2007







                                       3






                                  EXHIBIT INDEX


         Exhibit No.                Description

         Exhibit 99.1      Press Release of Blonder Tongue Laboratories, Inc.
                           dated May 15, 2007 regarding its unaudited financial
                           results for the first quarter ended March 31, 2007.

EX-99 2 blonderex99to8k051507.htm EARNINGS RELEASE
[LOGO]


                                                             One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353



   FOR IMMEDIATE RELEASE                   CONTACT:      James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000


               BLONDER TONGUE REPORTS 2007 FIRST QUARTER RESULTS

OLD BRIDGE, NEW JERSEY, May 15, 2007 - Blonder Tongue Laboratories,  Inc. (AMEX:
"BDR") today  announced its sales and earnings for the first quarter ended March
31, 2007.

Net  sales  for the  first  quarter  2007  decreased  24.7% to  $7,499,000  from
$9,957,000  for the first  quarter  2006.  The  decrease  in sales is  primarily
attributed  to a  decrease  in  the  sales  of  the  Company's  analog  headend,
distribution,  and interdiction products.  Headend product sales were $3,887,000
and  $5,050,000,  distribution  product sales were $1,463,000 and $1,963,000 and
interdiction  product  sales were $198,000 and $622,000 for the first quarter of
2007 and 2006, respectively.

Loss from continuing  operations  after income taxes was $842,000 or $(0.14) per
share for the first three months of 2007 compared to income of $317,000 or $0.04
per share for the comparable period in 2006.

Commenting on the first quarter 2007 results,  James A. Luksch,  Chief Executive
Officer,  said,  "Historically,  our first  quarter is usually  soft,  while our
second quarter shows improvement.  In 2006, our first quarter reaped the unusual
benefit of the  introduction  of several new product  offerings,  which have now
been fully  introduced  into the  marketplace.  We are still on course  with our
China initiative and we expect  noticeable  benefits from reduced costs to begin
in the second half of 2007, with further improvements thereafter."

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband  service  providers  in  the  multiple  dwelling  unit,   lodging  and
hospitality, and institutional cable markets. The Company designs, manufactures,
and  supplies a  comprehensive  line of  equipment  to deliver  video  (analog &
digital),  high speed data and voice services over integrated  coaxial and fiber
optic broadband networks today and over packet based, Internet protocol networks
of the future.  For more information  regarding  Blonder Tongue or its products,
please  visit the  Company's  Web site at  www.blondertongue.com  or contact the
Company directly at (732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2006 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  Blonder  Tongue's  actual
results may differ from the anticipated results or other expectations  expressed
in Blonder Tongue's "forward-looking" statements

                                     -MORE-



                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                                   Three months ended
                                                        March 31,
                                               ----------------------------
                                                   2007           2006

Net sales                                           $7,499         $9,957
Gross profit                                         2,495          3,298
Earnings (loss) from operations                       (724)           562
Earnings (loss ) from continuing operations           (842)           317
Loss from discontinued operations                        -           (125)
Net earnings (loss)                                  $(842)          $192
Basic and diluted earnings (loss) per share
from continuing operations                           (0.14)         $0.04
Basic and diluted loss per share from
discontinued operations                                  -          (0.02)
Basic and diluted net income (loss) per
share                                               $(0.14)         $0.02
Basic and diluted weighted average shares
outstanding:                                         6,222          8,015






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                              March 31,             December 31,
                                                 2007                   2006
                                              (unaudited)

Current assets                                   $14,227             $14,942
Property, plant, and equipment, net                4,451               4,537
Total assets                                      27,063              27,222
Current liabilities                                5,695               5,431
Long-term liabilities                              1,498               1,559
Stockholders' equity                              19,870              20,232

Total liabilities and stockholders' equity       $27,063             $27,222

                                       ###

-----END PRIVACY-ENHANCED MESSAGE-----